Validity of vascular calcification as a screening tool and as a surrogate end point in clinical research

Hypertension

Volumn 66, Issue 1, 2015, Pages 3-9

  Zoccali, Carmine ^a   Bolignano, Davide ^a   D'Arrigo, Graziella ^a   Dekker, Friedo W ^b   Fliser, Danilo ^c   Heine, Gunnar H ^c   Jager, Kitty J ^d   Kanbay, Mehmet ^e   Mallamaci, Francesca ^a   Massy, Ziad ^f   Ortiz, Alberto ^g   Parati, Gianfranco ^h   Rossignol, Patrick ^i,j,k,l   Tripepi, Giovanni ^a   Vanholder, Raymond ^m   Wiecek, Andrzej ⁿ   London, Gerard ^o  

^a CNR   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e KOÇ UNIVERSITY   (Turkey)

^f LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^g UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^h UNIVERSITY OF MILANO BICOCCA   (Italy)

ⁱ INSERM   (France)

^j UNIVERSITY HOSPITAL OF NANCY   (France)

^k UNIVERSITÉ DE LORRAINE   (France)

^l French Clinical Research Infrastructure Network (F CRIN)   (France)

^m GHENT UNIVERSITY HOSPITAL   (Belgium)

ⁿ MEDICAL UNIVERSITY OF SILESIA   (Poland)

^o HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

more..

Author keywords

2015 American Heart Association, Inc.

Indexed keywords

BLOOD VESSEL CALCIFICATION; CLINICAL RESEARCH; CORONARY ARTERY CALCIUM SCORE; HUMAN; LIFESTYLE; META ANALYSIS (TOPIC); PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SCREENING TEST; SYSTEMATIC REVIEW (TOPIC); VALIDITY; CALCINOSIS; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DYSLIPIDEMIAS; HYPERTENSION; MOTIVATION; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

BIOLOGICAL MARKER; CALCIUM;

BIOLOGICAL MARKERS; CALCINOSIS; CALCIUM; CORONARY ARTERY DISEASE; CORONARY VESSELS; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; META-ANALYSIS AS TOPIC; MOTIVATION; OBSERVATIONAL STUDY AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84939566020     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.04801     Document Type: Review

References (65)

1. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 385 117 71
2. Mehta D, Curwin J, Gomes JA, Fuster V., Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. Circulation 1997 96 3215 3223
3. Lloyd-Jones DM, Larson MG, Beiser A, Levy D., Lifetime risk of developing coronary heart disease. Lancet 1999 353 89 92. doi: 10.1016/S0140-6736(98)10279-9
4. Stone NJ, Robinson JG, Lichtenstein AH, Goff DC Jr, Lloyd-Jones DM, Smith SC Jr, Blum C, Schwartz JS, 2013 ACC/AHA Cholesterol Guideline Panel Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Intern Med 2014 160 339 343. doi: 10.7326/M14-0126
5. Perk J, De Backer G, Gohlke H, Comitato per Linee Guida Pratiche (CPG) dell'ESC European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). G Ital Cardiol (Rome) 2013 14 328 392. doi: 10.1714/1264.13964
6. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P., Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007 335 136. doi: 10.1136/bmj.39261.471806.55
7. Berry JD, Lloyd-Jones DM, Garside DB, Greenland P., Framingham risk score and prediction of coronary heart disease death in young men. Am Heart J 2007 154 80 86. doi: 10.1016/j.ahj.2007.03.042
8. Cooney MT, Dudina AL, Graham IM., Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol 2009 54 1209 1227. doi: 10.1016/j.jacc.2009.07.020
9. Wang TJ., Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 2011 123 551 565. doi: 10.1161/CIRCULATIONAHA.109.912568
10. Terry JG, Carr JJ, Tang R, Evans GW, Kouba EO, Shi R, Cook DR, Vieira JL, Espeland MA, Mercuri MF, Crouse JR 3rd, Coronary artery calcium outperforms carotid artery intima-media thickness as a noninvasive index of prevalent coronary artery stenosis. Arterioscler Thromb Vasc Biol 2005 25 1723 1728. doi: 10.1161/01.ATV.0000173418.42264.19
11. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, Greenland P., Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010 303 1610 1616. doi: 10.1001/jama.2010.461
12. Elias-Smale SE, Proença RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, Steyerberg EW, Hofman A, Oudkerk M, Witteman JC., Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol 2010 56 1407 1414. doi: 10.1016/j.jacc.2010.06.029
13. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP., Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013 382 339 352. doi: 10.1016/S0140-6736(13)60595-4
14. Stary HC., The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. Am J Cardiol 2001 88 2A 16E 19E
15. McEvoy JW, Blaha MJ, Defilippis AP, Budoff MJ, Nasir K, Blumenthal RS, Jones SR., Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol 2010 56 1613 1622. doi: 10.1016/j.jacc.2010.06.038
16. Wong ND, Detrano RC, Diamond G, Rezayat C, Mahmoudi R, Chong EC, Tang W, Puentes G, Kang X, Abrahamson D., Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? Am J Cardiol 1996 78 1220 1223
17. Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, Blumenthal RS, Budoff MJ., Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol 2008 101 999 1002. doi: 10.1016/j.amjcard.2007.11.059
18. Pletcher MJ, Pignone M., Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact. Circulation 2011 123 1116 1124. doi: 10.1161/CIRCULATIONAHA.110.943860
19. Greenland P, Alpert JS, Beller GA, American College of Cardiology Foundation; American Heart Association 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010 56 e50 103. doi: 10.1016/j.jacc.2010.09.001
20. Goff DC Jr, Lloyd-Jones DM, Bennett G, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014 63 25 Pt B 2935 2959. doi: 10.1016/j.jacc.2013.11.005
21. Whelton SP, Nasir K, Blaha MJ, Gransar H, Metkus TS, Coresh J, Berman DS, Blumenthal RS., Coronary artery calcium and primary prevention risk assessment: what is the evidence? An updated meta-Analysis on patient and physician behavior. Circ Cardiovasc Qual Outcomes 2012 5 601 607. doi: 10.1161/CIRCOUTCOMES.112.965566
22. Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Peats L, Wong ND, Rana JS, Orakzai R, Hayes SW, Friedman JD, Thomson LE, Polk D, Min J, Budoff MJ, Berman DS., Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol 2011 57 1622 1632. doi: 10.1016/j.jacc.2011.01.019
23. Sørensen MH, Gerke O, Lambrechtsen J, Sand NP, Mols R, Thomassen A, Larsen ML, Mickley H, Diederichsen AC., Changes in medical treatment six months after risk stratification with HeartScore and coronary artery calcification scanning of healthy middle-Aged subjects. Eur J Prev Cardiol 2012 19 1496 1502. doi: 10.1177/1741826711428063
24. Mamudu HM, Paul TK, Veeranki SP, Budoff M., The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review. Atherosclerosis 2014 236 338 350. doi: 10.1016/j.atherosclerosis.2014.07.022
25. Matsushita K, Sang Y, Ballew SH, Shlipak M, Katz R, Rosas SE, Peralta CA, Woodward M, Kramer HJ, Jacobs DR, Sarnak MJ, Coresh J., Subclinical atherosclerosis measures for cardiovascular prediction in CKD. J Am Soc Nephrol 2015 26 439 447. doi: 10.1681/ASN.2014020173
26. Criqui MH, Denenberg JO, Ix JH, McClelland RL, Wassel CL, Rifkin DE, Carr JJ, Budoff MJ, Allison MA., Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 2014 311 271 278. doi: 10.1001/jama.2013.282535
27. Ambrosius WT, Polonsky TS, Greenland P, Goff DC Jr, Perdue LH, Fortmann SP, Margolis KL, Pajewski NM., Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power. Clin Trials 2012 9 232 246. doi: 10.1177/1740774512436882
28. Greenland P., More evidence for coronary calcium as a measure of cardiovascular risk: has anything changed? JAMA 2014 311 247 248. doi: 10.1001/jama.2013.282536
29. McCullough PA, Chinnaiyan KM., Annual progression of coronary calcification in trials of preventive therapies: a systematic review. Arch Intern Med 2009 169 2064 2070. doi: 10.1001/archinternmed.2009.382
30. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD., Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 2005 46 166 172. doi: 10.1016/j.jacc.2005.02.089
31. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, Rumberger JA., Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 2005 112 563 571. doi: 10.1161/CIRCULATIONAHA.104.512681
32. Schmermund A, Achenbach S, Budde T, Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation 2006 113 427 437. doi: 10.1161/CIRCULATIONAHA.105.568147
33. Houslay ES, Cowell SJ, Prescott RJ, Reid J, Burton J, Northridge DB, Boon NA, Newby DE, Scottish Aortic Stenosis and Lipid Lowering Therapy, Impact on Regression Trial Investigators Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. Heart 2006 92 1207 1212. doi: 10.1136/hrt.2005.080929
34. Motro M, Shemesh J., Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 2001 37 1410 1413
35. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002 62 245 252. doi: 10.1046/j.1523-1755.2002.00434.x
36. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P., Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005 68 1815 1824. doi: 10.1111/j.1523-1755.2005.00600.x
37. Russo D, Miranda I, Ruocco C, Battaglia Y, Buonanno E, Manzi S, Russo L, Scafarto A, Andreucci VE., The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 2007 72 1255 1261. doi: 10.1038/sj.ki.5002518
38. Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M, CARE-2 Investigators A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008 51 952 965. doi: 10.1053/j.ajkd.2008.02.298
39. Barreto DV, Barreto Fde C, de Carvalho AB, Cuppari L, Draibe SA, Dalboni MA, Moyses RM, Neves KR, Jorgetti V, Miname M, Santos RD, Canziani ME., Phosphate binder impact on bone remodeling and coronary calcification-results from the BRiC study. Nephron Clin Pract 2008 110 c273 c283. doi: 10.1159/000170783
40. Budoff MJ, Ahmadi N, Gul KM, Liu ST, Flores FR, Tiano J, Takasu J, Miller E, Tsimikas S., Aged garlic extract supplemented with B vitamins, folic acid and L-Arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med 2009 49 101 107. doi: 10.1016/j.ypmed.2009.06.018
41. Terry JG, Carr JJ, Kouba EO, Davis DH, Menon L, Bender K, Chandler ET, Morgan T, Crouse JR III, Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). Am J Cardiol 2007 99 1714 1717. doi: 10.1016/j.amjcard.2007.01.060
42. Naci H, Brugts JJ, Fleurence R, Tsoi B, Toor H, Ades AE., Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-Analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol 2013 20 641 657. doi: 10.1177/2047487313480435
43. Wu B, Elmariah S, Kaplan FS, Cheng G, Mohler ER III, Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol 2005 25 592 597. doi: 10.1161/01.ATV.0000154278.01871.64
44. Burgstahler C, Reimann A, Beck T, Kuettner A, Baumann D, Heuschmid M, Brodoefel H, Claussen CD, Kopp AF, Schroeder S., Influence of a lipid-lowering therapy on calcified and noncalcified coronary plaques monitored by multislice detector computed tomography: results of the New Age II Pilot Study. Invest Radiol 2007 42 189 195. doi: 10.1097/01.rli.0000254408.96355.85
45. Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM., Morbidity and mortality in patients randomised to double-blind treatment with a long-Acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000 356 366 372. doi: 10.1016/S0140-6736(00)02527-7
46. Motro M, Shemesh J, Grossman E., Coronary benefits of calcium antagonist therapy for patients with hypertension. Curr Opin Cardiol 2001 16 349 355
47. Dvorak MM, De Joussineau C, Carter DH, Pisitkun T, Knepper MA, Gamba G, Kemp PJ, Riccardi D., Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-Transporter in bone. J Am Soc Nephrol 2007 18 2509 2516. doi: 10.1681/ASN.2007030348
48. Raggi P, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K, Moustafa M, Goodman WG, Lopez N, Downey G, Dehmel B, Floege J, ADVANCE Study Group The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2011 26 1327 1339. doi: 10.1093/ndt/gfq725
49. Kakuta T, Tanaka R, Hyodo T, Suzuki H, Kanai G, Nagaoka M, Takahashi H, Hirawa N, Oogushi Y, Miyata T, Kobayashi H, Fukagawa M, Saito A., Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients. Am J Kidney Dis 2011 57 422 431. doi: 10.1053/j.ajkd.2010.10.055
50. Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM., Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 2012 23 1407 1415. doi: 10.1681/ASN.2012030223
51. Lemos MM, Watanabe R, Carvalho AB, Jancikic AD, Sanches FM, Christofalo DM, Draibe SA, Canziani ME., Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study. Clin Nephrol 2013 80 1 8. doi: 10.5414/CN107630
52. Braun J, Asmus HG, Holzer H, Brunkhorst R, Krause R, Schulz W, Neumayer HH, Raggi P, Bommer J., Long-Term comparison of a calcium-free phosphate binder and calcium carbonate-phosphorus metabolism and cardiovascular calcification. Clin Nephrol 2004 62 104 115
53. Sadek T, Mazouz H, Bahloul H, Oprisiu R, El Esper N, El Esper I, Boitte F, Brazier M, Moriniere P, Fournier A., Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study. Nephrol Dial Transplant 2003 18 582 588
54. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM., Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007 71 438 441. doi: 10.1038/sj.ki.5002059
55. Suki WN, Dialysis Clinical Outcomes Revisited Investigators Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial. J Ren Nutr 2008 18 91 98. doi: 10.1053/j.jrn.2007.10.019
56. Di Iorio B, Bellasi A, Russo D, INDEPENDENT Study Investigators Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol 2012 7 487 493. doi: 10.2215/CJN.03820411
57. Di Iorio B, Molony D, Bell C, Cucciniello E, Bellizzi V, Russo D, Bellasi A, INDEPENDENT Study Investigators Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial. Am J Kidney Dis 2013 62 771 778. doi: 10.1053/j.ajkd.2013.03.023
58. Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, Lok CE, Fitchett D, Tsuyuki RT., Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-Analysis. Lancet 2013 382 1268 1277. doi: 10.1016/S0140-6736(13)60897-1
59. Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P., Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol 2007 2 898 905. doi: 10.2215/CJN.04381206
60. Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M., Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008 248 254 263. doi: 10.1148/radiol.2481071451
61. Picano E, Vañó E, Rehani MM, The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology. Eur Heart J 2014 35 665 672. doi: 10.1093/eurheartj/eht394
62. Madhavan MV, Tarigopula M, Mintz GS, Maehara A, Stone GW, Généreux P., Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol 2014 63 1703 1714. doi: 10.1016/j.jacc.2014.01.017
63. Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Ureña-Torres P, Bover J, Goldsmith D, CKD-MBD Working Group of ERA-EDTA Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol 2014 2 427 436. doi: 10.1016/S2213-8587(14)70059-2
64. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, Farkouh ME, Fayad ZA., Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging 2009 2 107 115. doi: 10.1161/CIRCIMAGING.108.811752
65. Abdelbaky A, Corsini E, Figueroa AL, Fontanez S, Subramanian S, Ferencik M, Brady TJ, Hoffmann U, Tawakol A., Focal arterial inflammation precedes subsequent calcification in the same location: a longitudinal FDG-PET/CT study. Circ Cardiovasc Imaging 2013 6 747 754. doi: 10.1161/CIRCIMAGING.113.000382.